Financing Strategies for Nanotechnology Companies – Boston

27 March 2007 Boston, MA Past Event

Location

Foley & Lardner LLP
111 Huntington Avenue
Boston, MA 02199

Agenda

8:15 a.m. – 10:00 a.m.

Do you have a strategy for responding to the temperamental IPO market and making the most of alternative financing strategies?

Foley & Lardner LLP and the NanoBusiness Alliance are pleased to invite senior business executives and investors to participate in a roundtable discussion addressing how nanotechnology companies can develop financing strategies for success.

Discussion topics include:

  • Financing growth and development of a nanotechnology company with long product development timelines, little or no near-term revenue, and potential applications in many industries
  • Determining when the sale of your company is the most viable and what factors have made other nanotechnology companies attractive targets
  • Deciding whether to go IPO, OTC, AIM, or private equity
  • Exploring nontraditional financing options
  • Positioning your company for the best financing options

Confirmed Boston Attendees:

  • Tim Cesarek, President, Koch Genesis Company, LLC
  • Mark Modzelewski, Vice President, NanoDynamics
  • Justin Hall-Tipping, Senior Managing Partner, NanoHoldings LLC
  • Scott Livingston, Managing Director, The Livingston Group, Axiom Capital Management Inc.
  • Curt Creely, Partner, Foley & Lardner LLP

Insights

PATH Summit 2019
18-20 December 2019
Arlington, VA
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.

Financing Strategies for Nanotechnology Companies – Boston

Location

Foley & Lardner LLP
111 Huntington Avenue
Boston, MA 02199

Agenda

8:15 a.m. – 10:00 a.m.